Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence.
Mélanie Dos SantosM LangeR GervaisB ClarisseA CapelM BarilletJ M GrellardN HeutteI LicajF JolyPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)
Non-adherence to oral anticancer therapies was mainly associated to depression. Focusing on depressive symptoms before initiation of oral anticancer therapy could help to identify patient profiles more likely to fail self-management. Working memory, digit memory, and short-term memory also seem to play a role in non-adherence. Further studies should include a more specific population, especially according to age.